92 related articles for article (PubMed ID: 11056001)
1. Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement.
Coral S; Fonsatti E; Sigalotti L; De Nardo C; Visintin A; Nardi G; Colizzi F; Colombo MP; Romano G; Altomonte M; Maio M
J Cell Physiol; 2000 Dec; 185(3):317-23. PubMed ID: 11056001
[TBL] [Abstract][Full Text] [Related]
2. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.
Brasoveanu LI; Fonsatti E; Visintin A; Pavlovic M; Cattarossi I; Colizzi F; Gasparollo A; Coral S; Horejsi V; Altomonte M; Maio M
J Clin Invest; 1997 Sep; 100(5):1248-55. PubMed ID: 9276743
[TBL] [Abstract][Full Text] [Related]
4. Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
De Nardo C; Fonsatti E; Sigalotti L; Calabrò L; Colizzi F; Cortini E; Coral S; Altomonte M; Maio M
J Cell Physiol; 2002 Feb; 190(2):200-6. PubMed ID: 11807824
[TBL] [Abstract][Full Text] [Related]
5. Targeted neutralization of the complement membrane attack complex inhibitor CD59 on the surface of human melanoma cells.
Junnikkala S; Hakulinen J; Meri S
Eur J Immunol; 1994 Mar; 24(3):611-5. PubMed ID: 7510237
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies.
Fonsatti E; Altomonte M; Coral S; De Nardo C; Lamaj E; Sigalotti L; Natali PG; Maio M
Clin Ter; 2000; 151(3):187-93. PubMed ID: 10958054
[TBL] [Abstract][Full Text] [Related]
8. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
[TBL] [Abstract][Full Text] [Related]
9. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement.
Walsh LA; Tone M; Waldmann H
Eur J Immunol; 1991 Mar; 21(3):847-50. PubMed ID: 1707009
[TBL] [Abstract][Full Text] [Related]
10. Effects of complement activation on the expression of CD59 by human mesangial cells.
Shibata T; Kohsaka T
J Immunol; 1995 Jul; 155(1):403-9. PubMed ID: 7541422
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter.
Holguin MH; Martin CB; Eggett T; Parker CJ
J Immunol; 1996 Aug; 157(4):1659-68. PubMed ID: 8759753
[TBL] [Abstract][Full Text] [Related]
12. Biotinylation of monoclonal antibodies prevents their ability to activate the classical pathway of complement.
Jokiranta TS; Meri S
J Immunol; 1993 Aug; 151(4):2124-31. PubMed ID: 7688394
[TBL] [Abstract][Full Text] [Related]
13. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
Xu C; Jung M; Burkhardt M; Stephan C; Schnorr D; Loening S; Jung K; Dietel M; Kristiansen G
Prostate; 2005 Feb; 62(3):224-32. PubMed ID: 15389793
[TBL] [Abstract][Full Text] [Related]
14. Anemia-inducing factor expressed in gastric cancer is homologous with complement regulatory factor CD59?
Mikami Y; Mikami M; Nannmoku H; Kawashima H; Sasaki T; Hada R; Inoue S
J Exp Clin Cancer Res; 1998 Sep; 17(3):355-60. PubMed ID: 9894775
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal mesothelial cells produce complement factors and express CD59 that inhibits C5b-9-mediated cell lysis.
Barbano G; Cappa F; Prigione I; Tedesco F; Pausa M; Gugliemino R; Pistoia V; Gusmano R; Perfumo F
Adv Perit Dial; 1999; 15():253-7. PubMed ID: 10682113
[TBL] [Abstract][Full Text] [Related]
18. Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.
Hakulinen J; Meri S
Immunology; 1995 Jul; 85(3):495-501. PubMed ID: 7558140
[TBL] [Abstract][Full Text] [Related]
19. C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.
Ollert MW; Frade R; Fiandino A; Panneerselvam M; Petrella EC; Barel M; Pangburn MK; Bredehorst R; Vogel CW
J Immunol; 1990 May; 144(10):3862-7. PubMed ID: 2185316
[TBL] [Abstract][Full Text] [Related]
20. Establishment of complement-resistant retroviral vector by homologous restriction factor 20 gene.
Hayashi S; Emi N; Okada H; Nagasaka T; Yokoyama I; Takagi H
Gene Ther; 1998 Feb; 5(2):282-5. PubMed ID: 9578850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
